Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease that affects over 30% of the world’s population. For decades, the heterogeneity of non-alcoholic fatty liver disease (NAFLD) has impeded our understanding of the disease mechanism...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, Hua Bian, Xin Gao, Mingfeng Xia
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-04-01
Serija:	Lipids in Health and Disease
Teme:	Metabolic dysfunction-associated fatty liver disease Hepatic lipid metabolism Multisystem disease Pathophysiology Medications Clinical trials
Online dostop:	https://doi.org/10.1186/s12944-024-02092-2
Oznake:	Označite Brez oznak, prvi označite!